NM_032856.5(WDR73):c.626G>A (p.Trp209Ter) AND Inborn genetic diseases

Germline classification:: Pathogenic (1 submission)
Last evaluated:: Feb 3, 2020
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001265694.4

Allele description [Variation Report for NM_032856.5(WDR73):c.626G>A (p.Trp209Ter)]

NM_032856.5(WDR73):c.626G>A (p.Trp209Ter)

Gene:

WDR73:WD repeat domain 73 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

15q25.2

Genomic location:

Preferred name:

NM_032856.5(WDR73):c.626G>A (p.Trp209Ter)

HGVS:

NC_000015.10:g.84645728C>T
NG_042034.1:g.13616G>A
NM_032856.5:c.626G>AMANE SELECT
NP_116245.2:p.Trp209Ter
NC_000015.9:g.85188959C>T
NM_032856.2:c.626G>A
NR_130944.2:n.1169G>A
NR_130945.2:n.748G>A
NR_130946.2:n.642G>A
NR_130947.2:n.546G>A

Protein change:

W209*

Links:

dbSNP: rs1896432430

NCBI 1000 Genomes Browser:

rs1896432430

Molecular consequence:

NR_130944.2:n.1169G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_130945.2:n.748G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_130946.2:n.642G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_130947.2:n.546G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NM_032856.5:c.626G>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:: Inborn genetic diseases
Identifiers:: MeSH: D030342; MedGen: C0950123

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001443861	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Pathogenic (Feb 3, 2020)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001443861

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Pathogenic
(Feb 3, 2020)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV001443861.4

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The alteration results in a premature stop codon: _x000D_ _x000D_ The c.626G>A (p.W209*) alteration, located in coding exon 7 of the WDR73 gene, results from a G to A substitution at nucleotide position 626. This changes the amino acid from a tryptophan (W) to a stop codon at amino acid position 209. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. The alteration is not observed in population databases: _x000D_ _x000D_ Based on data from the Genome Aggregation Database (gnomAD), the WDR73 c.626G>A alteration was not observed, with coverage at this position. Based on the available evidence, this alteration is classified as pathogenic.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: May 1, 2024

ClinVar

Relating variation to medicine